The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this “Connectivity Map” resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, post-perturbation transcriptomics data are particularly suited for training computational models because the causal relationship between known perturbations (cause) and the measured post-perturbation gene expression (effect) allows for the modelling of mechanistic processes [11].”
From Benchmarking foundation cell models for post-perturbation RNA-seq prediction (2025) · cites this paper as [11]
In the citing paper
“Both Alakwaa’ and Luo’s pipelines use the CLUE platform, a cloud-based platform developed by the LINCS Center for signature-gene based drug ranking61.”
From ASGARD is a single-cell guided pipeline to aid repurposing of drugs (2023) · cites this paper as [61]
In the citing paper
“For example, in a classic paradigm inflammatory bowel disease (IBD) signatures were derived from surgical specimens and intersected with Connectivity Map70 data representing transcriptional readouts across a number of cell lines in response to treatment with many hundreds of drugs using a novel pattern-matching algorithm71. From this research the anticonvulsant drug topiramate was identified and”
From Exploiting machine learning for end-to-end drug discovery and development (2019) · cites this paper as [71]
In the citing paper
“Useful tools will include maps of evolutionary conservation (108) and chromatin state (140), as well as databases of cell-state signatures, such as genome-wide expression patterns, that may integrate aspects of cell biology under resting and provoked conditions (141).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [141]
In the citing paper
“It has been shown that compounds eliciting similar transcriptional signatures tend to share mechanisms of action.170,207−209”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [207]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Self-citationMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533
Research works printed but not linked: 7
- K. B. Glaser et al., Mol. Cancer Ther.2, 151 (2003).
- A. E. Wakeling, M. Dukes, J. Bowler, Cancer Res.51, 3867 (1991).
- J. Y. Vanderhoek, M. B. Feinstein, Mol. Pharmacol.16, 171 (1979).
- H. Hieronymus et al. Cancer Cell in press.
- Q. Yao et al., Clin. Cancer Res.9, 4483 (2003).
- T. Kubota et al., Cancer Res.58, 3344 (1998).
- G. Wei et al. Cancer Cell in press.
Cited by
Items 701–800 of 1,037
Gmeiner, W. H., Reinhold, W. C., & Pommier, Y. G. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0674 · Cited by 89
Carrella, D., Napolitano, F., Rispoli, R., Miglietta, M. M., Carissimo, A., Cutillo, L., Sirci, F., Gregoretti, F., & di Bernardo, D. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu058 · Cited by 89
Abelin, J. G., Patel, J., Lu, X., Feeney, C. M., Fagbami, L., Creech, A. L., Hu, R., Lam, D., Davison, D., Pino, L., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.058354 · Cited by 87
Self-citationRahman, M. R., Islam, T., Göv, E., Turanlı, B., Gülfidan, G., Shahjaman, M., Banu, N. A., Mollah, M. N. H., Arğa, K. Y., & Moni, M. A. (2019) · Medicina · doi:10.3390/medicina55010020 · Cited by 89
Li, G., Zhang, C., Liang, W. P., Zhang, Y., Shen, Y., & Tian, X.-H. (2021) · Pharmaceutical Biology · doi:10.1080/13880209.2020.1865407 · Cited by 89
Arany, Z., Wagner, B. K., Ma, Y., Chinsomboon, J., Laznik, D., & Spiegelman, B. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800979105 · Cited by 82
Muroi, M., Kazami, S., Noda, K., Kondo, H., Takayama, H., Kawatani, M., Usui, T., & Osada, H. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.03.016 · Cited by 89
Kang, J., Hsu, C.-H., Wu, Q., Liu, S., Coster, A. D., Posner, B. A., Altschuler, S. J., & Wu, L. F. (2016) · Nature Biotechnology · doi:10.1038/nbt.3419 · Cited by 84
Zhao, J., Lv, C., Wu, Q., Zeng, H., Guo, X., Yang, J., Tian, S., & Zhang, W. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104365 · Cited by 89
An integrative machine learning approach for prediction of toxicity-related drug safety
Lysenko, A., Sharma, A., Boroevich, K. A., & Tsunoda, T. (2018) · Life Science Alliance · doi:10.26508/lsa.201800098 · Cited by 88
“In addition, incorporation of data from cell culture pro fi ling studies offered by the Connectivity Map (60) and the more recent Library of Integrated Network-based Cellular Signatures (61) could be another way of more fully capturing the complexity of drug responses.”
CRISPR Approaches to Small Molecule Target Identification
Jost, M., & Weissman, J. S. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00965 · Cited by 88
Systems medicine: evolution of systems biology from bench to bedside
Wang, R., Maron, B. A., & Loscalzo, J. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1297 · Cited by 89
User-friendly and industry-integrated AI for medicinal chemists and pharmaceuticals
Kapustina, O., Burmakina, P., Gubina, N., Serov, N., & Vinogradov, V. V. (2024) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2024.100072 · Cited by 88
Jiang, L., Dalgarno, C., Papalexi, E., Mascio, I., Wessels, H., Yun, H., Iremadze, N., Lithwick‐Yanai, G., Lipson, D., & Satija, R. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01622-z · Cited by 90
Bioinformatics methods in drug repurposing for Alzheimer’s disease
Siavelis, J. C., Bourdakou, M. M., Athanasiadis, E. I., Spyrou, G. M., & Nikita, K. S. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv048 · Cited by 87
Mine, K. L., Shulzhenko, N., Yambartsev, A., Rochman, M., Sanson, G. F. O., Lando, M., Varma, S., Skinner, J., Volfovsky, N., Deng, T., et al. (2013) · Nature Communications · doi:10.1038/ncomms2693 · Cited by 88
Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis
Hett, E. C., Slater, L. H., Mark, K. G., Kawate, T., Monks, B. G., Stutz, A., Latz, E., & Hung, D. T. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1236 · Cited by 88
Polymeropoulos, M. H., Licamele, L., Volpi, S., Mack, K., Mitkus, S. N., Carstea, E. D., Getoor, L. C., Thompson, A. D., & Lavedan, C. N. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.11.025 · Cited by 90
A systematic protocol for the characterization of Hsp90 modulators
Matts, R. L., Brandt, G. E. L., Lu, Y., Dixit, A., Mollapour, M., Wang, S., Donnelly, A. C., Neckers, L. Μ., Verkhivker, G. M., & Blagg, B. S. J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.10.029 · Cited by 88
Shen, S., Zhang, P., Lovchik, M. A., Li, Y., Tang, L.-Y., Chen, Z., Zeng, R., Ma, D., Yuan, J., & Yu, Q. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200810183 · Cited by 88
Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches
Kubota, K., Funabashi, M., & Ogura, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.08.002 · Cited by 88
Xu, J., Zhang, P., Huang, Y., Zhou, Y., Hou, Y., Bekris, L. M., Lathia, J., Chiang, C.-W., Li, L., Pieper, A. A., et al. (2021) · Genome Research · doi:10.1101/gr.272484.120 · Cited by 84
Kaufman, J. M., Amann, J. M., Park, K., Arasada, R. R., Li, H., Shyr, Y., & Carbone, D. P. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000173 · Cited by 87
“Transcription factor analysis was performed using the Broad Institute’s Molecular Signature Database,13,14 and initial perturbation analysis was performed using the Connectivity Map.15 Detailed information on data sources and statistical comparisons made for various analyses is given in Supplementary Table S1 (Supplem…”
MethodATF6α regulates morphological changes associated with senescence in human fibroblasts
Druelle, C., Drullion, C., Deslé, J., Martin, N., Saas, L., Cormenier, J., Malaquin, N., Huot, L., Slomianny, C., Bouali, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11505 · Cited by 87
Machine learning approaches for drug combination therapies
Güvenç Paltun, B., Kaski, S., & Mamitsuka, H. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab293 · Cited by 87
Wang, Z., Su, G.-H., Dai, Z., Meng, M., Zhang, H., Fan, F., Liu, Z., Zhang, L., Weygant, N., He, F., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.12988 · Cited by 87
Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs
Daley, S.-K., & Cordell, G. A. (2021) · Molecules · doi:10.3390/molecules26133800 · Cited by 87
Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence
Hsieh, K., Wang, Y., Chen, L., Zhao, Z., Savitz, S. I., Jiang, X., Tang, J. P., & Kim, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-02353-5 · Cited by 87
Pan-cancer analysis reveals molecular patterns associated with age
Shah, Y., Verma, A., Marderstein, A. R., White, J. B., Bhinder, B., Medina, J. S. G., & Elemento, O. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110100 · Cited by 88
Ahmed, F., Samantasinghar, A., Soomro, A. M., Kim, S., & Choi, K. H. (2023) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2023.104373 · Cited by 87
Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer's Disease
Kim, T. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0325-7 · Cited by 89
Bayesian Group Factor AnalysisPreprint
Virtanen, S., Klami, A., Khan, S. A., & Kaski, S. (2011) · arXiv (Cornell University) · doi:10.48550/arxiv.1110.3204 · Cited by 87
Exploring the epigenetic drug discovery landscape
Prachayasittikul, V., Prathipati, P., Pratiwi, R., Phanus‐umporn, C., Malik, A. A., Schaduangrat, N., Seenprachawong, K., Wongchitrat, P., Supokawej, A., Prachayasittikul, V., et al. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1295954 · Cited by 86
Vidović, D., Koleti, A., & Schürer, S. C. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00342 · Cited by 86
Mapping the effects of drugs on the immune system
Kidd, B. A., Wroblewska, A., Boland, M. R., Agudo, J., Mérad, M., Tatonetti, N. P., Brown, B. D., & Dudley, J. T. (2016) · Nature Biotechnology · doi:10.1038/nbt.3367 · Cited by 86
Prediction of disease–gene–drug relationships following a differential network analysis
Zickenrott, S., Angarica, V. E., Upadhyaya, B. B., & del Sol, A. (2016) · Cell Death & Disease · doi:10.1038/cddis.2015.393 · Cited by 75
Drug repurposing for cancer therapy, easier said than done
González‐Fierro, A., & Dueñas‐González, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.012 · Cited by 85
Liu, D., Shoag, J. E., Poliak, D., Goueli, R. S., Ravikumar, V., Redmond, D., Vosoughi, A., Fontugne, J., Pan, H., Lee, D. C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15913-6 · Cited by 85
Becker, L. M., Chen, S.-H., Rodor, J., de Rooij, L. P. M. H., Baker, A. H., & Carmeliet, P. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac018 · Cited by 85
Tuddenham, J. F., Taga, M. F., Haage, V. C., Marshe, V. S., Roostaei, T., White, C. C., Lee, A., Fujita, M., Khairallah, A., Zhang, Y., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01764-7 · Cited by 85
Zhang, S.-D., & Gant, T. W. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-236 · Cited by 81
Cheng, T., Li, Q., Wang, Y., & Bryant, S. H. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200192v · Cited by 85
A systems biology approach to identify effective cocktail drugs
Wu, Z., Zhao, X., & Chen, L. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-s2-s7 · Cited by 85
miR-638 regulates gene expression networks associated with emphysematous lung destruction
Christenson, S. A., Brandsma, C., Campbell, J. D., Knight, D. A., Pechkovsky, D. V., Hogg, J. C., Timens, W., Postma, D. S., Lenburg, M. E., & Spira, A. E. (2013) · Genome Medicine · doi:10.1186/gm519 · Cited by 85
ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis
Chong, Y. K., Sandanaraj, E., Koh, L., Thangaveloo, M., Tan, M. S. Y., Koh, G. R. H., Toh, T. B., Lim, G. G. Y., Holbrook, J. D., Kon, O. L., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv326 · Cited by 85
HSP90 Inhibitors for Cancer Therapy and Overcoming Drug Resistance
Jhaveri, K. L., & Modi, S. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-397927-8.00015-4 · Cited by 85
Applied machine learning in Alzheimer's disease research: omics, imaging, and clinical data
Li, Z., Jiang, X., Wang, Y., & Kim, Y. (2021) · Emerging Topics in Life Sciences · doi:10.1042/etls20210249 · Cited by 65
Matheny, C. J., Wei, M. C., Bassik, M. C., Donnelly, A. J., Kampmann, M., Iwasaki, M., Piloto, O., Solow-Cordero, D. E., Bouley, D. M., Rau, R., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.014 · Cited by 74
Qiu, C., Chen, G., & Cui, Q. (2012) · Scientific Reports · doi:10.1038/srep00318 · Cited by 84
Lan, A., Smoly, I. Y., Rapaport, G., Lindquist, S., Fraenkel, E., & Yeger‐Lotem, E. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr359 · Cited by 85
ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery
Saei, A. A., Beusch, C. M., Chernobrovkin, A., Sabatier, P., Zhang, B., Tokat, Ü. G., Stergiou, E., Gaetani, M., Végvári, Á., & Zubarev, R. A. (2019) · Nature Communications · doi:10.1038/s41467-019-13582-8 · Cited by 81
Judson, R., Elloumi, F., Setzer, R. W., Li, Z., & Shah, I. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-241 · Cited by 83
The liver pharmacological and xenobiotic gene response repertoire
Natsoulis, G., Pearson, C. I., Gollub, J., Eynon, B. P., Ferng, J., Nair, R. V., Idury, R., Lee, M. D., Fielden, M. R., Brennan, R., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.9 · Cited by 83
Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model
Stessman, H. A. F., Baughn, L. B., Sarver, A., Xia, T., Deshpande, R., Mansoor, A., Walsh, S. A., Sunderland, J. J., Dolloff, N. G., Linden, M. A., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1151 · Cited by 79
Stepping into the omics era: Opportunities and challenges for biomaterials science and engineering
Gröen, N., Güvendiren, M., RABITZ, H. A., Welsh, W. J., Kohn, J., & de Boer, J. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.02.015 · Cited by 83
Environmental surveillance and monitoring—The next frontiers for high-throughput toxicology
Schroeder, A. L., Ankley, G. T., Houck, K. A., & Villeneuve, D. L. (2016) · Environmental Toxicology and Chemistry · doi:10.1002/etc.3309 · Cited by 83
Iwata, M., Sawada, R., Iwata, H., Kotera, M., & Yamanishi, Y. (2017) · Scientific Reports · doi:10.1038/srep40164 · Cited by 84
Genetic circuit characterization and debugging using RNA‐seq
Gorochowski, T. E., Borujeni, A. E., Park, Y., Nielsen, A. A. K., Zhang, J., Der, B. S., Gordon, D. B., & Voigt, C. A. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167461 · Cited by 83
Niculescu, A. B., Le-Niculescu, H., Roseberry, K., Wang, S., Hart, J., Kaur, A., Robertson, H., Jones, T., Strasburger, A., Williams, A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0602-2 · Cited by 75
Napoli, E., Siracusa, L., & Ruberto, G. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.201900677 · Cited by 83
Target identification of small molecules based on chemical biology approaches
Futamura, Y., Muroi, M., & Osada, H. (2013) · Molecular BioSystems · doi:10.1039/c2mb25468a · Cited by 82
Natural heat shock protein 90 inhibitors in cancer and inflammation
Costa, T. E. M. M., Raghavendra, N. M., & Penido, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112063 · Cited by 84
Recent advances in drug repurposing using machine learning
Urbina, F., Puhl, A. C., & Ekins, S. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.06.001 · Cited by 82
Jiang, W., Chen, X., Liao, M., Li, W., Lian, B., Wang, L., Meng, F., Liu, X., Chen, X., Jin, Y., et al. (2012) · Scientific Reports · doi:10.1038/srep00282 · Cited by 82
Hübel, K., Leßmann, T., & Waldmann, H. (2008) · Chemical Society Reviews · doi:10.1039/b704729k · Cited by 82
Oncogenic gene fusions in epithelial carcinomas
Prensner, J. R., & Chinnaiyan, A. M. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.008 · Cited by 82
Iron chelators target both proliferating and quiescent cancer cells
Fryknäs, M., Zhang, X., Bremberg, U., Senkowski, W., Olofsson, M. H., Brandt, P., Persson, I., D’Arcy, P., Gullbo, J., Nygren, P., et al. (2016) · Scientific Reports · doi:10.1038/srep38343 · Cited by 82
Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells
Agnihotri, S., Mansouri, S., Burrell, K., Li, M., Mamatjan, Y., Liu, J., Nejad, R., Kumar, S., Jalali, S., Singh, S. K., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1854 · Cited by 73
Szalai, B., Subramanian, V., Holland, C. H., Alföldi, R., Puskás, L. G., & Saez-Rodriguez, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz805 · Cited by 69
A Multi-Omics Interpretable Machine Learning Model Reveals Modes of Action of Small Molecules
Patel-Murray, N. L., Adam, M., Huynh, N. C., Wassie, B. T., Milani, P., & Fraenkel, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-57691-7 · Cited by 81
Iwata, H., Sawada, R., Mizutani, S., & Yamanishi, Y. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500670q · Cited by 81
Beesley, A. H., Firth, M. J., Ford, J., Weller, R. E., Freitas, J. R., Perera, K. U., & Kees, U. R. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605072 · Cited by 81
Feliu, N., Kohonen, P. J., Ji, J., Zhang, Y., Karlsson, H. L., Palmberg, L., Nyström, A. M., & Fadeel, B. (2014) · ACS Nano · doi:10.1021/nn5061783 · Cited by 81
Hassane, D. C., Sen, S., Minhajuddin, M., Rossi, R. M., Corbett, C. A., Balys, M. M., Wei, L., Crooks, P. A., Guzmán, M. L., & Jordan, C. T. (2010) · Blood · doi:10.1182/blood-2010-04-278044 · Cited by 81
Chang, M., Smith, S., Thorpe, A., Barratt, M. J., & Karim, F. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-56 · Cited by 75
Drug-set enrichment analysis: a novel tool to investigate drug mode of action
Napolitano, F., Sirci, F., Carrella, D., & di Bernardo, D. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btv536 · Cited by 75
Chen, J., & Zhang, S. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw059 · Cited by 82
Molecular signature of anastasis for reversal of apoptosis
Tang, H. M., Talbot, C. C., Fung, M. C., & Tang, H. L. (2017) · F1000Research · doi:10.12688/f1000research.10568.2 · Cited by 82
Sandor, C., Robertson, P., Lang, C., Heger, A., Booth, H., Vowles, J., Witty, L., Bowden, R., Hu, M., Cowley, S. A., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddw412 · Cited by 74
Expression-based drug screening of neural progenitor cells from individuals with schizophrenia
Readhead, B., Hartley, B. J., Eastwood, B. J., Collier, D. A., Evans, D., Farias, R., He, C., Hoffman, G., Sklar, P., Dudley, J. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06515-4 · Cited by 75
Insights into Computational Drug Repurposing for Neurodegenerative Disease
Paranjpe, M. D., Taubes, A., & Sirota, M. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.06.003 · Cited by 70
Kinaret, P., Serra, A., Federico, A., Kohonen, P. J., Nymark, P. E. H., Liampa, I., Ha, M. K., Choi, J., Jagiełło, K., Sanabria, N. M., et al. (2020) · Nanomaterials · doi:10.3390/nano10040750 · Cited by 81
Skeletal Muscle Atrophy: Discovery of Mechanisms and Potential Therapies
Ebert, S. M., Al-Zougbi, A., Bodine, S. C., & Adams, C. M. (2019) · Physiology · doi:10.1152/physiol.00003.2019 · Cited by 80
Chen, J., Schlitzer, A., Chakarov, S., Ginhoux, F., & Poidinger, M. (2016) · Nature Communications · doi:10.1038/ncomms11988 · Cited by 74
Yang, J., Li, A., Li, Y., Guo, X., & Wang, M. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty848 · Cited by 80
Cox, M. J., Jaensch, S., de Waeter, J. V., Cougnaud, L., Seynaeve, D., Benalla, S., Koo, S. J., den Wyngaert, I. V., Neefs, J., Malkov, D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69354-8 · Cited by 80
Funato, K., Smith, R. C., Saito, Y., & Tabar, V. S. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.02.003 · Cited by 80
Targeting macrophage TFEB-14-3-3 epsilon Interface by naringenin inhibits abdominal aortic aneurysm
Jia, Y., Zhang, L., Liu, Z., Mao, C., Ma, Z., Li, W., Yu, F., Wang, Y., Huang, Y., Zhang, W., et al. (2022) · Cell Discovery · doi:10.1038/s41421-021-00363-1 · Cited by 80
Sctensor detects many-to-many cell–cell interactions from single cell RNA-sequencing data
Tsuyuzaki, K., Ishii, M., & Nikaido, I. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05490-y · Cited by 80
Using Functional Signature Ontology (FUSION) to Identify Mechanisms of Action for Natural Products
Potts, M. B., Kim, H. S., Fisher, K. W., Hu, Y., Carrasco, Y. P., Bulut, G. B., Ou, Y.-H., Herrera‐Herrera, M. L., Cubillos, F., Mendiratta, S., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004657 · Cited by 80
Enhancing the Promise of Drug Repositioning through Genetics
Pritchard, J.-L. E., O’Mara, T. A., & Glubb, D. M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00896 · Cited by 73
Zhang, J. D., Berntenis, N., Roth, A., & Ebeling, M. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.39 · Cited by 79
Setoain, J., Franch, M., Martínez, M., Tabas-Madrid, D., Sorzano, C. O. S., Bakker, A., Gonzalez-Couto, E., Elvira, J., & Pascual-Montano, A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv445 · Cited by 76
Ahmed, J., Meinel, T., Dunkel, M., Murgueitio, M. S., Adams, R. A., Blasse, C., Eckert, A. P., Preißner, S., & Preißner, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq910 · Cited by 79
Oshida, K., Vasani, N. B., Thomas, R. S., Applegate, D. R., Rosen, M., Abbott, B. D., Lau, C. S., Guo, G. L., Aleksunes, L. M., Klaassen, C. D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0112655 · Cited by 79
Hu, Y., Potts, M. B., Colosimo, D. A., Herrera‐Herrera, M. L., Legako, A. G., Yousufuddin, M., White, M. A., & MacMillan, J. B. (2013) · Journal of the American Chemical Society · doi:10.1021/ja403412y · Cited by 79
Chen, M.-H., Yang, W.-L. R., Lin, K.-T., Liu, C.-H., Liu, Y.-W., Huang, K.-W., Chang, P. M.-H., Lai, J.-M., Hsu, C.-N., Chao, K.-M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027186 · Cited by 75
Gene Signatures in the Management of Hepatocellular Carcinoma
Hoshida, Y., Moeini, A., Alsinet, C., Kojima, K., & Villanueva, A. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.003 · Cited by 79
Chemical biology and the limits of reductionism
Peterson, R. T. (2008) · Nature Chemical Biology · doi:10.1038/nchembio1108-635 · Cited by 79
Nelson, E. A., Sharma, S. V., Settleman, J. E., & Frank, D. A. (2011) · Oncotarget · doi:10.18632/oncotarget.296 · Cited by 80
Metadata
- Authors
- Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G., Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Crawford, Emily D.
- Golub, Todd R.
- ORCID
- Venue
- Science
- Published
- 2006-09-29
- Volume
- 313
- Issue
- 5795
- Pages
- 1929-1935
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2121604817
- Cited by
- 5,257
- References
- 41
- Citations by year
- 2026: 226 · 2025: 285 · 2024: 332 · 2023: 370 · 2022: 416 · 2021: 406 · 2020: 383 · 2019: 385 · 2018: 280 · 2017: 288 · 2016: 296 · 2015: 259 · 2014: 217 · 2013: 241 · 2012: 219
- FWCI
- 118.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene expression signatures, small molecules, drug action, gene perturbation, mechanism of action, cultured human cells, functional genomics
- MeSH terms
- Alzheimer Disease, Cell Line, Dexamethasone, Drug Evaluation, Preclinical, Enzyme Inhibitors, Estrogens, Humans, Obesity, Phenothiazines, Software, Gene Expression, Databases, Factual, HSP90 Heat-Shock Proteins, Drug Resistance, Neoplasm, Sirolimus, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Limonins, Cell Line, Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.